<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="emmm201910938-fig-0004" orientation="portrait" position="float">
 <label>Figure 4</label>
 <caption>
  <title>
   <styled-content style="fixed-case" toggle="no">AAV</styled-content>‐vectored vaccines but not 
   <styled-content style="fixed-case" toggle="no">WIV</styled-content> induce broadly reactive FcγR‐activating antibodies
  </title>
  <p>
   <list list-type="simple" id="emmm201910938-list-0005">
    <list-item>
     <label>A, B</label>
     <p>Influenza virus‐specific activation of the murine FcγRI, FcγRII, FcγRIII, and FcγRIV by antibodies in pooled pre‐challenge sera (AAV‐HA, ‐cHA, ‐GFP, WIV 
      <italic>n</italic> = 18, AAV‐NP 
      <italic>n</italic> = 11 mice per group). MDCKII cells were infected with Cal/7/9 (A) or PR8 (B) before mouse serum and FcγR‐expressing reporter cells were added. Influenza‐specific Fc‐FcγR interaction induces the production of IL‐2 in the FcγR‐expressing reporter cell, which was measured by anti‐IL2 ELISA (
      <italic>n</italic> = 3, technical duplicates). Mean ± SE.
     </p>
    </list-item>
    <list-item>
     <label>C</label>
     <p>HA‐specific activation of FcγR by AAV‐HA, AAV‐cHA, or WIV pooled pre‐challenge sera (
      <italic>n</italic> = 18 mice per group). MDCKII cells were transfected with wild‐type HA (pAAV‐HA) or a stalk‐only HA (pAAV‐mHL1) before mouse serum and FcγR‐I‐expressing reporter cells were added (
      <italic>n</italic> = 2, technical duplicates). Mean ± SE.
     </p>
    </list-item>
   </list>
  </p>
 </caption>
 <graphic id="nlm-graphic-17" xlink:href="EMMM-12-e10938-g008" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
